Ecovyst Inc. (ECVT)
NYSE: ECVT · Real-Time Price · USD
13.81
+0.48 (3.60%)
At close: May 22, 2026, 4:00 PM EDT
13.84
+0.03 (0.23%)
After-hours: May 22, 2026, 7:25 PM EDT

Ecovyst Earnings Call Transcripts

Fiscal Year 2026

  • AGM 2026

    The meeting confirmed a quorum and proceeded with three proposals: director elections, executive compensation approval, and auditor ratification. All proposals passed, and results will be filed with the SEC.

  • Strong Q1 growth in regeneration services and virgin sulfuric acid drove a 50% sales increase and 87% higher adjusted EBITDA year-over-year. Guidance for 2026 was raised, and the Calabrian acquisition is set to expand the product portfolio and market reach.

Fiscal Year 2025

  • Strong Q4 and full-year 2025 results exceeded guidance, driven by higher sulfuric acid sales and favorable pricing. The business was transformed by a major divestiture, debt reduction, and strategic acquisitions, positioning for growth in 2026 with a robust balance sheet and active capital returns.

  • Announced sale of a major segment to Technip Energies, with proceeds to reduce debt and fund growth. Q3 saw strong sales and EBITDA growth, driven by pricing and mining demand, despite refinery outages. 2025 guidance raised for free cash flow, with a focus on organic growth, capital returns, and a strengthened balance sheet.

  • M&A Announcement

    The acquisition of AM&C for $556 million expands capabilities in catalysts and advanced materials, increases recurring revenue, and is expected to be accretive to earnings and margins. Integration will focus on cross-selling and new business generation, with full synergies expected in two to three years.

  • Q2 2025 saw strong financial results, with sales and EBITDA exceeding guidance, driven by stable demand, the Waggaman acquisition, and robust performance in hydrocracking catalysts. Guidance for full-year sales, Zeolyst JV, and free cash flow was raised, while leverage increased due to acquisitions and share repurchases.

  • First quarter results exceeded expectations, led by strong Zeolyst JV performance and stable core businesses. Full-year guidance was maintained, with sales outlook raised due to higher sulfur cost pass-throughs, and opportunistic share repurchases prioritized.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Powered by